Moderna COVID-19 vaccine conferred at least 3 months of immunity — study. A study showed Thursday that Moderna COVID-19 vaccine, which the company said was recently demonstrated to have 94% efficacy, caused the human immune system to produce potent antibodies that could endure for at least three months. Researchers at NIAID (National Institute for Allergies … Read more
Moderna had planned to start testing its COVID-19 vaccine in children. Moderna on Wednesday announced that the company had planned to start testing its coronavirus vaccine in children ages 12 to 17. In a report on ABS-CBN News, the said study — listed Wednesday on clinicaltrials.gov — was to include 3,000 children wherein half will … Read more
Moderna applied to US FDA for an emergency use authorization of its COVID-19 vaccine. Moderna on Monday applied to the Food and Drug Administration in the United States (US FDA) for emergency use authorization (EUA) of its COVID-19 vaccine. This, as Moderna asked the US FDA to review an expanded data set showing that the … Read more
DOH reminded the public that the Philippine government had no registered COVID-19 vaccine yet. The Department of Health (DOH) on Monday reminded the public that the Philippine government had no registered COVID-19 vaccine yet. For a vaccine to be approved in the country, the manufacturer must secure clearance from the Food and Drug Administration (FDA), … Read more
Pfizer and BioNTech sought first COVID-19 vaccine approval in the United States. Pharmaceuticals companies Pfizer and BioNTech on Friday had sought an approval to release their jointly-developed COVID-19 vaccine early in the United States as a first step towards relief. This, as the increasing number of coronavirus infections prompted a return to shutdowns that traumatized … Read more
Pfizer had ended its clinical trials for COVID-19 vaccine with 95% efficacy. Pfizer Inc. on Wednesday said that the final results from the late-stage trial of its COVID-19 vaccine show it was 95% effective Also, Pfizer said that it had the required two months of safety data and will apply for an emergency use authorization … Read more
Pfizer was “very close” to applying for an emergency use approval, according to the company’s CEO Pfizer’s CEO on Tuesday said that Pfizer was “very close” to applying for an emergency use approval (EUA) for its COVID-19 vaccine, according to a report. This, after the company began collecting safety data to submit to regulators in … Read more
